# OnCo record paper-empower-cscc-1-j-am-acad-dermatol-2025-update (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-empower-cscc-1-j-am-acad-dermatol-2025-update/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-empower-cscc-1-j-am-acad-dermatol-2025-update" ;
  schema:name "A phase 2 open-label study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (EMPOWER-CSCC-1): Final long-term analysis of groups 1, 2, and 3, and primary analysis of fixed-dose treatment group 6"@en ;
  schema:description "Later report from the EMPOWER-CSCC-1 trial registered as NCT02760498, in Journal of the American Academy of Dermatology (2025); its title describes an updated or longer-term analysis."@en ;
  schema:url <https://onco.cc/key-papers/paper-empower-cscc-1-j-am-acad-dermatol-2025-update/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/j.jaad.2024.06.108>, <https://pubmed.ncbi.nlm.nih.gov/39245360/>, <https://europepmc.org/article/MED/39245360>, <https://clinicaltrials.gov/study/NCT02760498> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1016/j.jaad.2024.06.108> ;
  schema:datePublished "2025"^^xsd:gYear ;
  schema:author "Hughes BGM, Guminski A, Bowyer S, et al." ;
  onco:trials <https://onco.cc/trials/empower-cscc-1/> .